Bulls-eye on your analysis. I noticed that my borrowed shares (sh lending program, Fidelity) are now being returned. I have had 4 returns and no new borrowing. Two weeks ago all were borrowed and now only half that. Those are the smart shorts. Looks like $4 is good support.
Hoping for a great day. This stock should be much higher ! Twitter is garbage compared to FB.
Sentiment: Strong Buy
Travel tips from the president of Long Beach's World Wide Travel. Kathy Lerner operates her travel agency, World Wide Travel Inc., out of her home in Long Beach. Lerner said travel agents offer a level of expertise that can't be found with online ...
Re: Atala: "Much work remains to be done before hESC and induced pluripotent stem cell therapies go beyond regulatory trials, but the path is now set in motion."
"....market potentially as early as 2019. "
February 26, 2015
Ocata Therapeutics Approved for Listing on NASDAQ
The purpose of the pivotal SMD trial is to determine efficacy and safety, as well as to assess relevant functional and anatomical parameters of cell transplantation using an untreated control group, with the intent of bringing a product to market potentially as early as 2019.
Wotton: "Over in Europe we believe we might be able to get that product to market towards the end of 2018, but we are targeting 2019."
Roadshow: Ocata Therapeutics, Inc. (IPO)
Published on Dec 6, 2014
Lanza: "Any treatment might not be ready for FDA approval until 2020..."
Tuesday, October 14, 2014
Published study shows: ACT treatment restores some sight
By Lisa Eckelbecker TELEGRAM & GAZETTE STAFF
"We treated the last UK patients last month, and they also have not seen any safety issues related to the transplanted tissues themselves, either," Dr. Lanza said. Advanced Cell now hopes to launch a 100-patient, phase 2 study in Stargardt's patients by the end of the year, according to Dr. Lanza. A second, smaller phase 2 study in patients with age-related macular degeneration would follow, he said. Any treatment might not be ready for FDA approval until 2020, Dr. Lanza said.
Schwartz: "It's not ready. Maybe in a few years. Maybe not. We have to wait and see. The jury is way out still."
Embryonic Stem Cells Restore Vision In Preliminary Human Test
October 14, 2014
For his part, Schwartz says he's just trying to help blind people see better. But he cautions that this work is still at a very early stage. "I don't want patients to come in to their doctor saying, 'Hey, I heard about the stem cells on the radio and I'd really like to get that treatment done, and what do you think?' " he says. "It's not ready. Maybe in a few years. Maybe not. We have to wait and see. The jury is way out still."
: ) Life begins where land ends !
No offense, "lottawatta" but if you've stuck with this loser, you ARE one!
Sentiment: Strong Sell
No, Korea is not a REALITY until a 3rd party can Independently verify that this "deal" has taken place. KB has lied in PR's WAT too many times for anyone to EVER take him seriously without Independent Verification.
Good luck on getting that.